United Therapeutics
UTHR
UTHR
411 hedge funds and large institutions have $6.46B invested in United Therapeutics in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 153 increasing their positions, 143 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
5% less capital invested
Capital invested by funds: $6.81B → $6.46B (-$347M)
5.74% less ownership
Funds ownership: 112% → 106.25% (-5.7%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
411
Holding in Top 10
6
Calls
$82.5M
Puts
$85.8M
Top Buyers
| 1 | +$627M | |
| 2 | +$51.1M | |
| 3 | +$38.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.7M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$29.1M |
Top Sellers
| 1 | -$119M | |
| 2 | -$41.6M | |
| 3 | -$34.8M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$34.1M |
| 5 |
STMM
South Texas Money Management
San Antonio,
Texas
|
-$26.8M |